Heart Pump Device Market, By Type (Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices), By Product (Intra-aortic Balloon Pumps, Ventricular Assist Devices (RVAD, LVAD, pVAD, BiVAD), and TAH (Total Artificial Heart)), By Therapy (Destination Therapy, Bridge to Transplant, and Others), By End-Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI506923 | Publish Date: February 2024 | No. of Pages: 175

Heart Pump Device Market Companies

  • Medtronic plc.
  • Abbott Laboratories
  • Johnson & Johnson Services Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Terumo Medical Corporation
  • Thoratec Corporation
  • Teleflex Inc.
  • Getinge AB

Recent News:

  • The FDA (Food and Drug Administration) approved ABIOMED's new model, the "Impella RP Flex," in October 2022. This model is less invasive and simpler to wear than a conventional cardiac pump for treating right-sided heart failure. Following implantation, patients will find it easier to walk using the new "Impella RP Flex" gadget.
  • A surgical method using Abbott's HeartMate 3 heart pump was approved by the Food and Drug Administration (FDA) in January 2020, enabling patients with more advanced heart failure to skip open heart surgery. Surgeons will now have more surgical choices for HeartMate 3 patients because to this strategy.
  • By acquiring Essential Medical Inc., the company behind the MANTA Vascular Closure Device, in October 2018, Teleflex Inc. increased its market share in the endovascular aneurysm repair and structural heart industries.